Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients

Nephrology

Volumn 10, Issue 3, 2005, Pages 264-269

  Kahraman, Serkan ^a   Yilmaz, Rahmi ^a   Kirkpantur, Alper ^a   Genctoy, Gultekin ^a   Arici, Mustafa ^a   Altun, Bulent ^a   Erdem, Yunus ^a   Yasavul, Unal ^a   Turgan, Cetin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Anaemia; Cellular adhesion molecules; rHuEPO

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PLACEBO; RECOMBINANT ERYTHROPOIETIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANEMIA; CELL ADHESION MOLECULES; E-SELECTIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 21344459839     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00405.x     Document Type: Article

References (30)

1. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251: 788-91.
2. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-50.
3. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203.
4. Schmidt AM, Hori O, Chen JX et al. Advanced glycation end-products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1 ) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 1995; 96: 1395-403.
5. Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: Pathological significance. Ann. N. Y. Acad. Sci. 1992; 667: 324-31.
6. Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 1998; 79: 399-407.
7. Rabb H, Calderon E, Bittle PA, Ramirez G. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients. Am. J. Kidney Dis. 1996; 27: 239-43.
8. Mrowka C, Heintz B, Sieberth HG. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis? Clin. Nephrol. 1999; 52: 312-21.
9. Papayianni A, Alexopoulos E, Giamalis P et al. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: Association with inflammation, dyslipidaemia, and vascular events. Nephrol. Dial. Transplant. 2002; 17: 435-41.
10. Vaziri ND. Mechanism of erythropoietin-induced hypertension. Am. J. Kidney Dis. 1999; 33: 821-8.
11. Vaziri ND. Vascular effects of erythropoietin and anemia correction. Semin. Nephrol. 2000; 20: 356-63.
12. Langenfeld MR, Veelken R, Schobel HP, Friedrich A, Schmieder RE. Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension? Nephrol. Dial. Transplant. 1997; 12: 1155-60.
13. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 1999; 45: 2136-41.
14. Stenvinkel P, Lindholm B, Heimburger M, Heimburger O. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol. Dial. Transplant. 2000; 15: 1624-30.
15. Papagianni A, Kokolina E, Kalovoulos M, Vainas A, Dimitriadis C, Memmos D. Carotid atherosclerosis is associated with inflammation, malnutrition and intercellular adhesion molecule-1 in patients on continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant. 2004; 19: 1258-63.
16. Papagianni A, Kalovoulos M, Kirmizis D et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol. Dial. Transplant. 2003; 18: 113-19.
17. Ribatti D, Presta M, Vacca A et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999; 93: 2627-36.
18. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl. Acad. Sci. USA 1990; 87: 5978-82.
19. Carlini RG, Alonzo EJ, Dominguez J et al. Effect of recombinant human erythropoietin on endothelial cell apoptosis. Kidney Int. 1999; 55: 546-53.
20. Jelkmann W. Erythropoietin: Structure, control of production and function. Physiol. Rev. 1992; 72: 449-89.
21. Stohlawetz PJ, Dzirlo L, Hergovich N et al. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 2000; 95: 2983-9.
22. Stefanidis I, Mertens PR, Wurth P et al. Influence of recombinant human erythropoietin therapy on plasma endothelin-1 levels during hemodialysis. Int. J. Artif. Organs 2001; 24: 367-73.
23. Kuriyama S, Hopp L, Yoshida H et al. Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients. Am. J. Hypertens. 1996; 9: 426-31.
24. Aguilera A, Aguilera A, Selgas R et al. Effects of recombinant human erythropoietin on functional and injury endothelial markers in peritoneal dialysis patients. Perit. Dial. Int. 1999; 19 (Suppl. 2): 161-6.
25. De Marchi S, Cecchin E, Falleti E et al. Long-term effects of erythropoietin therapy on fistula stenosis and plasma concentrations of PDGF and MCP-1 in hemodialysis patients. J. Am. Soc. Nephrol. 1997; 8: 1147-56.
26. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl Acad. Sci. USA 1993; 90: 4304-8.
27. Hillis GS, Flapan AD. Cell adhesion molecules in cardiovascular disease: A clinical perspective. Heart 1998; 79: 429-31.
28. Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb. Haemost. 1994; 72: 151-4.
29. Zeitler H, Ko Y, Zimmermann C et al. Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. Eur. J. Med. Res. 1997; 2: 389-94.
30. Ridker PM, Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88-92.